Global Nutrigenomics Market is valued at approximately USD 435.7 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 17.2% during the forecast period 2023-2030.

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly treatment in patients with type 2 diabetes ...

The US Food and Drug Administration (FDA) is to conduct reviews into the abortion drug mifepristone, infant formula, and talc, while health secretary Robert F Kennedy Jr expressed support for broader ...

As we prepare for a hotter-than-normal summer, it's important to be aware that the heat can worsen certain health conditions.

The global konjac market was valued at $922.5 million in 2020, and is projected to reach $1,800.0 million by 2030, registering a CAGR of 7.1% WILMINGTON, DE, UNITED STATES, June 25, 2025 /EINPresswire ...

"Rising liver disease cases and biotech innovations are fueling demand for advanced therapies, with personalized medicine and fibrosis-targeting treatments shaping the global market landscape." BOSTON ...

Women with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...

A lower-sodium Dietary Approaches to Stop Hypertension-style diet was associated with clinically meaningful BP reduction in ...

Women who replaced their lunchtime diet beverage with water had greater weight loss and achieved diabetes remission compared ...

Type 2 diabetes remission and weight loss rates are significantly higher among adults who replace diet beverages with water.